225 related articles for article (PubMed ID: 28033528)
21. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
22. Risk of developing second malignant neoplasms in patients with neuroblastoma: a population study of the US SEER database.
Zhen H; Guan H; Ma J; Wang W; Jing S; Miao Z; Zhang F; Liu Z
Radiat Oncol; 2021 Nov; 16(1):228. PubMed ID: 34838090
[TBL] [Abstract][Full Text] [Related]
23. Risk of Subsequent Neoplasms During the Fifth and Sixth Decades of Life in the Childhood Cancer Survivor Study Cohort.
Turcotte LM; Whitton JA; Friedman DL; Hammond S; Armstrong GT; Leisenring W; Robison LL; Neglia JP
J Clin Oncol; 2015 Nov; 33(31):3568-75. PubMed ID: 26261260
[TBL] [Abstract][Full Text] [Related]
24. Incidence of second primary cancers in North Portugal-a population-based study.
Pacheco-Figueiredo L; Antunes L; Bento MJ; Lunet N
J Cancer Surviv; 2016 Feb; 10(1):142-52. PubMed ID: 26159159
[TBL] [Abstract][Full Text] [Related]
25. Second malignant neoplasms in childhood malignant brain tumour: a long-term population-based study.
Cai Y; Cao L; Bao X; Xie L
J Paediatr Child Health; 2012 Nov; 48(11):990-6. PubMed ID: 23039967
[TBL] [Abstract][Full Text] [Related]
26. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074
[TBL] [Abstract][Full Text] [Related]
27. Second cancer risk in childhood cancer survivors treated with intensity-modulated radiation therapy (IMRT).
Casey DL; Friedman DN; Moskowitz CS; Hilden PD; Sklar CA; Wexler LH; Wolden SL
Pediatr Blood Cancer; 2015 Feb; 62(2):311-316. PubMed ID: 25328040
[TBL] [Abstract][Full Text] [Related]
28. Second malignant neoplasms following treatment for Wilm's tumor: a report from the National Wilms' Tumor Study Group.
Breslow NE; Takashima JR; Whitton JA; Moksness J; D'Angio GJ; Green DM
J Clin Oncol; 1995 Aug; 13(8):1851-9. PubMed ID: 7636528
[TBL] [Abstract][Full Text] [Related]
29. Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: A cohort study within PanCareSurFup.
Allodji RS; Hawkins MM; Bright CJ; Fidler-Benaoudia MM; Winter DL; Alessi D; Fresneau B; Journy N; Morsellino V; Bárdi E; Bautz A; Byrne J; Feijen ELA; Teepen JC; Vu-Bezin G; Rubino C; Garwicz S; Grabow D; Gudmundsdottir T; Guha J; Hau EM; Jankovic M; Kaatsch P; Kaiser M; Linge H; Muraca M; Llanas D; Veres C; Øfstaas H; Diallo I; Mansouri I; Ronckers CM; Skinner R; Terenziani M; Wesenberg F; Wiebe T; Sacerdote C; Jakab Z; Haupt R; Lähteenmäki P; Zaletel LZ; Kuehni CE; Winther JF; Michel G; Kremer LCM; Hjorth L; Haddy N; de Vathaire F; Reulen RC
Eur J Cancer; 2019 Aug; 117():71-83. PubMed ID: 31260818
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcomes in survivors of neuroblastoma: a report from the Childhood Cancer Survivor Study.
Laverdière C; Liu Q; Yasui Y; Nathan PC; Gurney JG; Stovall M; Diller LR; Cheung NK; Wolden S; Robison LL; Sklar CA
J Natl Cancer Inst; 2009 Aug; 101(16):1131-40. PubMed ID: 19648511
[TBL] [Abstract][Full Text] [Related]
31. Long-term population-based risks of second malignant neoplasms after childhood cancer in Britain.
Jenkinson HC; Hawkins MM; Stiller CA; Winter DL; Marsden HB; Stevens MC
Br J Cancer; 2004 Nov; 91(11):1905-10. PubMed ID: 15534607
[TBL] [Abstract][Full Text] [Related]
32. Long-term risk of subsequent cancer incidence among hereditary and nonhereditary retinoblastoma survivors.
Schonfeld SJ; Kleinerman RA; Abramson DH; Seddon JM; Tucker MA; Morton LM
Br J Cancer; 2021 Mar; 124(7):1312-1319. PubMed ID: 33473166
[TBL] [Abstract][Full Text] [Related]
33. Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study.
Takahashi K; Wang F; Kantarjian H; Doss D; Khanna K; Thompson E; Zhao L; Patel K; Neelapu S; Gumbs C; Bueso-Ramos C; DiNardo CD; Colla S; Ravandi F; Zhang J; Huang X; Wu X; Samaniego F; Garcia-Manero G; Futreal PA
Lancet Oncol; 2017 Jan; 18(1):100-111. PubMed ID: 27923552
[TBL] [Abstract][Full Text] [Related]
34. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
Teepen JC; van Leeuwen FE; Tissing WJ; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; Neggers SJCMM; Jaspers MWM; Hauptmann M; van der Heiden-van der Loo M; Visser O; Kremer LCM; Ronckers CM;
J Clin Oncol; 2017 Jul; 35(20):2288-2298. PubMed ID: 28530852
[TBL] [Abstract][Full Text] [Related]
35. Secondary colorectal carcinoma after childhood cancer.
Nottage K; McFarlane J; Krasin MJ; Li C; Srivastava D; Robison LL; Hudson MM
J Clin Oncol; 2012 Jul; 30(20):2552-8. PubMed ID: 22665546
[TBL] [Abstract][Full Text] [Related]
36. Second malignancies after childhood noncentral nervous system solid cancer: Results from 13 cancer registries.
Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Olsen JH; Tracey E; Pukkala E; Weiderpass E; Brewster DH; Tamaro S; Chia KS; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
Int J Cancer; 2011 Oct; 129(8):1940-52. PubMed ID: 21520035
[TBL] [Abstract][Full Text] [Related]
37. Second malignant neoplasms in long-term survivors of osteosarcoma: Memorial Sloan-Kettering Cancer Center Experience.
Aung L; Gorlick RG; Shi W; Thaler H; Shorter NA; Healey JH; Huvos AG; Meyers PA
Cancer; 2002 Oct; 95(8):1728-34. PubMed ID: 12365021
[TBL] [Abstract][Full Text] [Related]
38. Risk of second malignant neoplasms after childhood central nervous system malignant tumours: an international study.
Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Pukkala E; Weiderpass E; Olsen JH; Tracey E; McBride ML; Brewster DH; Pompe-Kirn V; Tonita JM; Kliewer EV; Chia KS; Jonasson JG; Martos C; Magnani C; Boffetta P
Eur J Cancer; 2008 Apr; 44(6):830-9. PubMed ID: 18329873
[TBL] [Abstract][Full Text] [Related]
39. Risk Factors and Trends for HPV-Associated Subsequent Malignant Neoplasms among Adolescent and Young Adult Cancer Survivors.
Ou JY; Bennion N; Parker K; Fair D; Hanson HA; Kepka D; Warner EL; Ramsay JM; Kaddas HK; Kirchhoff AC
Cancer Epidemiol Biomarkers Prev; 2023 May; 32(5):625-633. PubMed ID: 37071501
[TBL] [Abstract][Full Text] [Related]
40. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma.
Kleinerman RA; Tucker MA; Abramson DH; Seddon JM; Tarone RE; Fraumeni JF
J Natl Cancer Inst; 2007 Jan; 99(1):24-31. PubMed ID: 17202110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
